FI960027L - Yhdisteitä, joilla on hCG:n antigeenisuus - Google Patents

Yhdisteitä, joilla on hCG:n antigeenisuus Download PDF

Info

Publication number: FI960027L
Authority: FI; Finland
Prior art keywords: hcg; antigenicity; compounds; hcg antigenicity
Prior art date: 1993-07-06

Application number

FI960027A

Other languages

English (en)

Swedish (sv)

Other versions

FI960027A0 (fi

FI960027A7 (fi

Inventor

James N Herron

Original Assignee

Univ Utah Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-06

Filing date

1994-07-06

Publication date

1996-01-03

1994-07-06 Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found

1996-01-03 Publication of FI960027A0 publication Critical patent/FI960027A0/fi

1996-01-03 Publication of FI960027L publication Critical patent/FI960027L/fi

1996-01-03 Publication of FI960027A7 publication Critical patent/FI960027A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)

FI960027A 1993-07-06 1994-07-06 Yhdisteitä, joilla on hCG:n antigeenisuus FI960027A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/089,994 US5380668A (en)	1993-07-06	1993-07-06	Compounds having the antigenicity of hCG
PCT/US1994/007605 WO1995001993A1 (en)	1993-07-06	1994-07-06	COMPOUNDS HAVING THE ANTIGENICITY OF hCG

Publications (3)

Publication Number	Publication Date
FI960027A0 FI960027A0 (fi)	1996-01-03
FI960027L true FI960027L (fi)	1996-01-03
FI960027A7 FI960027A7 (fi)	1996-01-03

Family

ID=22220572

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI960027A FI960027A7 (fi)	1993-07-06	1994-07-06	Yhdisteitä, joilla on hCG:n antigeenisuus

Country Status (8)

Country	Link
US (1)	US5380668A (fi)
EP (1)	EP0708784A1 (fi)
JP (1)	JPH08512325A (fi)
KR (1)	KR960703942A (fi)
AU (1)	AU698501B2 (fi)
CA (1)	CA2166385A1 (fi)
FI (1)	FI960027A7 (fi)
WO (1)	WO1995001993A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5919712A (en)	1993-05-18	1999-07-06	University Of Utah Research Foundation	Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
US6319504B1 (en)	1996-06-24	2001-11-20	University Of Maryland Biotechnology Institute	Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5968513A (en) *	1996-06-24	1999-10-19	University Of Maryland Biotechnology Institute	Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US5997871A (en) *	1996-06-24	1999-12-07	University Of Maryland Biotechnology Insitute	Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en)	1997-06-24	2003-06-24	Robert C. Gallo	Therapeutic polypeptides from β-hCG and derivatives
US7175679B2 (en) *	2001-03-29	2007-02-13	Biotempt B.V.	Oligopeptide treatment of NF-κB mediated inflammation
US20040202645A1 (en) *	2003-04-08	2004-10-14	Khan Nisar Ahmed	Administration of gene-regulatory peptides
US6844315B2 (en) *	1998-05-20	2005-01-18	Erasmus Universiteit Rotterdam	Immunoregulator
US6921751B1 (en)	1998-05-20	2005-07-26	Erasmus Universiteit Rotterdam	Immunoregulator
EP1138692A1 (en)	2000-03-29	2001-10-04	Erasmus Universiteit Rotterdam	Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US20050227925A1 (en) *	2004-04-08	2005-10-13	Robbert Benner	Compositions capable of reducing elevated blood urea concentration
US8680059B2 (en) *	1998-05-20	2014-03-25	Biotempt B.V.	Oligopeptide acetate and formulations thereof
US20030220258A1 (en) *	2001-12-21	2003-11-27	Robbert Benner	Treatment of ischemic events
US7994278B1 (en)	1999-08-06	2011-08-09	Nobel Biosciences Llc	Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US7576174B2 (en) *	2000-03-29	2009-08-18	Biotempt B.V.	Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) *	2001-10-04	2003-04-09	Erasmus Universiteit Rotterdam	Gene regulation by oligopeptides
USRE43279E1 (en)	2000-03-29	2012-03-27	Biotemp B.V.	Compositions capable of reducing elevated blood urea concentration
US20050037430A1 (en) *	2000-03-29	2005-02-17	Biotempt B.V.	Methods and uses for protein breakdown products
US7358330B2 (en)	2001-03-29	2008-04-15	Biotempt B.V.	Immunoregulatory compositions
CN1172717C (zh) *	2000-08-18	2004-10-27	清华大学	一种治疗艾滋病的药物及其制备方法
WO2002089731A2 (en)	2001-05-03	2002-11-14	Stanford University	Agents for treatment of hcv and methods of use
FR2827170B1 (fr) *	2001-07-13	2004-07-16	Soc Extraction Principes Actif	Utilisation de peptides pour augmenter l'adhesion cellulaire
US20030220259A1 (en) *	2001-12-21	2003-11-27	Robbert Benner	Treatment of neurological disorders
US20030108563A1 (en) *	2001-11-07	2003-06-12	Chander Bahl	Reagents for the simultaneous detection of HCV core antigens and antibodies
US7501391B2 (en) *	2001-12-21	2009-03-10	Biotempt B.V.	Treatment of transplant survival
US20040013661A1 (en) *	2001-12-21	2004-01-22	Gert Wensvoort	Stratification
US20030220261A1 (en) *	2001-12-21	2003-11-27	Khan Nisar Ahmed	Treatment of iatrogenic disease
US20030220260A1 (en) *	2001-12-21	2003-11-27	Khan Nisar Ahmed	Peptide compositions
US20080318871A1 (en) *	2001-12-21	2008-12-25	Khan Nisar A	Treatment of neurological disorders
US7560433B2 (en) *	2001-12-21	2009-07-14	Biotempt B.V.	Treatment of multiple sclerosis (MS)
US20030224995A1 (en) *	2001-12-21	2003-12-04	Khan Nisar Ahmed	Treatment of burns
US20080242837A1 (en) *	2001-12-21	2008-10-02	Khan Nisar A	Peptide compositions
US20030220257A1 (en) *	2001-12-21	2003-11-27	Robbert Benner	Treatment of trauma
US7786084B2 (en) *	2001-12-21	2010-08-31	Biotempt B.V.	Treatment of burns
US7517529B2 (en) *	2003-04-08	2009-04-14	Biotempt B.V.	Treatment of type I diabetes
US7625542B2 (en) *	2003-04-25	2009-12-01	Inframat Corporation	Method for the production of metal carbides
US20090227505A1 (en) *	2004-01-07	2009-09-10	Biotempt B.V.	Methods and uses for protein breakdown products
EP1904086A2 (en) *	2005-07-05	2008-04-02	Biotempt B.V.	Treatment of tumors
EP1864692A1 (en) *	2006-06-07	2007-12-12	Biotempt B.V.	Use of peptides for the control of radiation injury
PT2120991E (pt) *	2007-02-12	2014-05-02	Biotempt Bv	Tratamento d a hemorragia traumática com oligopéptidos curtos
EP2109054A1 (en)	2008-04-09	2009-10-14	Biotempt B.V.	Methods for identifying biologically active peptides and predicting their function
EP2490021A1 (en)	2011-02-18	2012-08-22	Biotempt B.V.	Modulators of PRR and GPCR signalling

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4071314A (en) *	1973-01-08	1978-01-31	Laboratoire Theranol	Processes, reagents and means for early diagnosis of pregnancy
US4116776A (en) *	1976-04-19	1978-09-26	International Radioimmune Systems, Inc.	Diagnostic blood test and kit for detecting human chorionic gonadotropin
JPS5781447A (en) *	1980-11-11	1982-05-21	Toyo Jozo Co Ltd	Human chorionic gonadotropic hormone c-terminal fragment
EP0138854B1 (en) *	1983-03-08	1992-11-04	Chiron Mimotopes Pty. Ltd.	Antigenically active amino acid sequences
JPH07119760B2 (ja) *	1984-07-24	1995-12-20	コモンウエルス・セ−ラム・ラボラトリ−ズ・コミッション	ミモトープを検出または決定する方法
NZ215865A (en) *	1985-04-22	1988-10-28	Commw Serum Lab Commission	Method of determining the active site of a receptor-binding analogue
US4789734A (en) *	1985-08-06	1988-12-06	La Jolla Cancer Research Foundation	Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US4804626A (en) *	1986-10-22	1989-02-14	The General Hospital Corporation	Immunometric assay for the detection of human chorionic gonadotropin
GB8701432D0 (en) *	1987-01-22	1987-02-25	Unilever Plc	Assays
JPH04504416A (ja) *	1989-02-17	1992-08-06	コセルコ・ミモトープス・ピィ・ティ・ワイ．エル・ティ・ディ．	ペプチドの使用方法と合成方法

1993
- 1993-07-06 US US08/089,994 patent/US5380668A/en not_active Expired - Lifetime
1994
- 1994-07-06 AU AU73244/94A patent/AU698501B2/en not_active Ceased
- 1994-07-06 EP EP94923353A patent/EP0708784A1/en not_active Withdrawn
- 1994-07-06 FI FI960027A patent/FI960027A7/fi not_active Application Discontinuation
- 1994-07-06 JP JP7504149A patent/JPH08512325A/ja active Pending
- 1994-07-06 KR KR1019960700023A patent/KR960703942A/ko not_active Withdrawn
- 1994-07-06 WO PCT/US1994/007605 patent/WO1995001993A1/en not_active Ceased
- 1994-07-06 CA CA002166385A patent/CA2166385A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR960703942A (ko)	1996-08-31
AU698501B2 (en)	1998-10-29
CA2166385A1 (en)	1995-01-19
WO1995001993A1 (en)	1995-01-19
EP0708784A1 (en)	1996-05-01
JPH08512325A (ja)	1996-12-24
FI960027A0 (fi)	1996-01-03
AU7324494A (en)	1995-02-06
FI960027A7 (fi)	1996-01-03
US5380668A (en)	1995-01-10

Publication	Publication Date	Title
FI960027A7 (fi)	1996-01-03	Yhdisteitä, joilla on hCG:n antigeenisuus
TR28005A (tr)	1995-11-03	Izopren-butadienli kaucuk.
FI896179A0 (fi)	1989-12-21	Lagerbestaendiga, synnerligen poroesa, kalorifattiga livsmedelsprodukter.
EP0655440A3 (de)	1996-11-06	Indol derivate.
FI923072A0 (fi)	1992-07-02	Maongstegsbindemedel foer anvaendning i elastomerbelaeggningar, mastixbelaeggningar, dikt- och taetningsmedel.
EP0626553A3 (en)	1995-02-22	Ignition element.
EP0679132A4 (en)	1996-05-29	ENGINE BEARING.
EP0657163A4 (en)	1995-12-13	ANTITUSSIVA.
FI933980A0 (fi)	1993-09-10	Skyddsplagg foer hygienkraevande objekt, saosom operationssalar
TR27962A (tr)	1995-11-06	Ikame edilmis 2-aril-oksazinler ve -tiyazinler.
FR2702259B1 (fr)	1997-01-31	Viscocoupleur.
FI923542A0 (fi)	1992-08-06	Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner.
ITMI931785A0 (it)	1993-08-06	Valilamidi di 7x-amino-1, 1-dioxo-cefem
FR2713451B1 (fr)	1996-01-26	Pince - accroche - canne.
FI930961A0 (fi)	1993-03-04	Matstation foer koettboskap, saerskilt svin
ES1024679Y (es)	1994-06-01	Visera-pañoleta.
FR2706039B1 (fr)	1995-08-04	Logomètre.
ES1026990Y (es)	1995-01-16	Pijama.
ES1024502Y (es)	1994-05-01	Contenedor-expositor.
FI931133A0 (fi)	1993-03-15	Eldslaeckningsmedel, eldslaeckningsmedelblandning
FI933095A0 (fi)	1993-07-05	Nyckel, saerskilt staellbar nyckel
FI932663A0 (fi)	1993-06-10	Presenning, saosom byggnadspresenning
FI931443A0 (fi)	1993-03-30	Nyckelloest, osynligt saekerhetslaos
FI930249A0 (fi)	1993-01-22	Vattentaet, sjaelvlaosande, laett oeppningsbar inspektionslucka (brunnslock)
FI900674A0 (fi)	1990-02-12	Skruvfraes, saerskilt dikesfraes.

Legal Events

Date	Code	Title	Description
1999-01-31	FD	Application lapsed